Topic: Trading Tips

Suspension

None

Resuming

000657 China Tungsten High-Tech

[Hot spot]

* ST Huayi: The company's shares will be terminated and delisted on January 16, 2024

* ST Huayi (600290) announced on the evening of January 9 that the company received the Shanghai Stock Exchange's "Decision on the Termination of the Listing of Huayi Electric Co., Ltd." on January 9, 2024, and the Shanghai Stock Exchange decided to terminate the listing of the company's shares. The company's shares will not enter the delisting period and will be terminated and delisted on January 16, 2024.

iFLYTEK: Proposed spin-off of subsidiary iFLYTEK Medical to be listed on the Hong Kong Stock Exchange

iFLYTEK (002230) announced on the evening of January 9 that the company intends to spin off its holding subsidiary iFLYTEK Medical to the main board of the Hong Kong Stock Exchange for listing. After the completion of this spin-off, HKUST Xunfei will still maintain control of Xunfei Medical. After the completion of the spin-off and listing, iFLYTEK Medical will obtain financing through the Hong Kong capital market, which will help iFLYTEK Medical continue to maintain its leading position in the field of medical artificial intelligence, and increase its international influence, thereby enhancing the comprehensive competitiveness of listed companies.

Sijin Intelligence: Up to now, the company has no direct business orders related to humanoid robots

sijin intelligence (003025) released a notice on abnormal stock trading fluctuations and risk warnings on the evening of January 9. the recent online cold forging (cold forming/cold heading) process is related to humanoid robots. up to now, the company has no direct business orders related to humanoid robots. At present, the company's leading product is multi-station high-speed automatic cold forming equipment, which is mainly used to manufacture various metal parts in a certain size range at room temperature, and is the main working machine for the production of fasteners and special-shaped parts in plastic forming process.

Dalian Shengya: No major changes have taken place in production and business activities at present

Dalian Shengya (600593) issued a stock trading risk warning announcement on the evening of January 9. The company's main business is mainly the operation of the polar aquarium scenic area, the commercial operation in the scenic area and the animal operation. The company's current production and operation activities have not undergone major changes.

[M & A]

China tungsten hi-tech: plans to purchase 100% equity of shizhuyuan company to resume trading on January 10

China Tungsten High-tech (000657) announced on the evening of January 9 that the company intends to purchase 100 percent of Shizhuyuan Company held by Minmetals Tungsten and Woxi Mining by issuing shares and paying cash. The main business of Shizhuyuan Company is the mining and selection of tungsten, molybdenum, bismuth, fluorite and other polymetallic ores, the smelting and processing of tungsten concentrate and the research and development of bismuth-based new materials. This transaction will help China Tungsten High-tech to form a complete tungsten industry chain integrating tungsten mining, tungsten smelting, cemented carbide and deep processing, integrate resources, promote industrial transformation and upgrading, and enhance the listed company's ability to resist operational risks. The company's shares will resume trading on January 10, 2024.

[Operating Results]

Commodity City: 2023 Net Profit Up 140-149 YoY

Commodity City (600415) issued a performance forecast on the evening of January 9. It is expected to achieve a net profit of 2.65 billion -2.75 billion yuan attributable to shareholders of listed companies in 2023, an increase of 140-149 compared with the same period last year. During the reporting period, the company continued to iterate online platform functions, strengthen digital trade service capabilities, the main business gross margin effectively improved. During the reporting period, the chinagoods platform GMV exceeded 65 billion yuan, up more than 80% year on year. Yiwu China Commodity City Big Data Co., Ltd. (the chinagoods operating entity) has a net profit of over 80 million yuan for the whole year. Since the company's own payment brand "Yiwu Pay" was officially launched on February 21, 2023, it has opened cross-border RMB accounts for nearly 20000 merchants, with cross-border clearing funds exceeding RMB 8.5 billion yuan. The company's cross-border RMB business achieved a leap-forward development from 0 to 1, and Fast Express Payment Services Co., Ltd. (the operating entity of "Yiwu Pay") made a profit that year.

Shenzhou Taiyue: net profit in 2023 increased by 53.17-71.62 year on year

Shenzhou Taiyue (300002) released a performance forecast on the evening of January 9, with an estimated net profit of 0.83 billion -0.93 billion yuan in 2023, up 53.17-71.62 year on year. During the reporting period, the company, with its major products such as "Age of Origins" ("City of the Rising Sun") and "War and Order" ("War and Order"), was firmly in the forefront of the ranking of Chinese game manufacturers' overseas revenue, with the company's game business accounting for nearly 90% of overseas revenue.

core ruida: net profit in 2023 increased by 50%-75% year on year

xinruida (002983) released its performance forecast on the evening of January 9, with an estimated net profit of 0.159 billion -0.185 billion yuan in 2023, up 50%-75% year on year. During the reporting period, benefiting from the accelerated penetration of Mini LED technology applications and the enlargement of the market scale, the company's display module business volume increased, the company strengthened the construction of marketing management capacity, display terminal business customer order access increased, thickening net profit.

Guizhou sanli: net profit in 2023 increased by 42.58-52.77 year on year

Guizhou Sanli (603439) issued a performance forecast on the evening of January 9. It is estimated that the net profit attributable to shareholders of listed companies will be 0.287 billion yuan to 0.308 billion yuan in 2023, an increase of 42.58 to 52.77 compared with the same period last year.%. In the first and fourth quarters of 2023, the incidence of throat diseases and influenza in China increased significantly, and the demand for related drugs increased significantly. The company's core products, open throat sword spray and open throat sword spray (children's type), have strong market demand and increased sales.

qinan shares: 2023 net profit increased by 37.95-54.5% year on year

Qin'an shares (603758) issued a performance forecast on the evening of January 9. It is estimated that the net profit attributable to shareholders of listed companies in 2023 will be 0.25 billion to 0.28 billion yuan, a year-on-year increase of 37.95 to 54.50. The increase in net profit was mainly due to the company's active adjustment of customer and product structure, strengthening internal management, reducing costs and increasing efficiency.

Sichuan investment energy: 2023 net profit of 4.403 billion yuan increased by 25.26 year on year

Sichuan Investment Energy (600674) released a performance bulletin on the evening of January 9, achieving total operating income of 1.486 billion billion yuan in 2023, a year-on-year increase of 4.61; net profit of 4.403 billion billion yuan, a year-on-year increase of 25.26; basic earnings per share of 0.99 yuan. The main reasons for the increase in total operating income during the reporting period were that the income of the subsidiary Tianwanhe Company increased by 0.04 billion yuan compared with last year, and the second was the operating income of the new subsidiary Guangxi Yuchai Nongguang Power Co., Ltd.

shengmei Shanghai: expected operating income between 5 billion yuan and 5.8 billion yuan in 2024

shengmei Shanghai (688082) announced on the evening of January 9 that it would realize operating income of 3.65 billion -4.25 billion yuan in 2023, up 27.04-47.93 over the same period last year. Based on the business development trend in recent years and the current orders and other aspects, the company expects that the annual operating income in 2024 will be between 5 billion yuan and 5.8 billion yuan.

China Industrial International: 2023 net profit pre-increased by 1.79-7.78% YoY

China Industrial International (002051) released its performance forecast on the evening of January 9. It is estimated that the net profit in 2023 will be 0.34 billion -0.36 billion yuan, up 1.79-7.78 year on year. During the reporting period, the company actively participated in the process of new industrialization, increased the layout of strategic emerging industries, and continued to optimize the business layout. The company's domestic and foreign business development momentum was good, and its operating performance continued to improve.

kangtai biology: expected net profit of 0.85 billion yuan -0.95 billion yuan in 2023 to turn losses year on year

kangtai biology (300601) released its performance forecast on the evening of January 9, with an estimated net profit of 0.85 billion -0.95 billion yuan in 2023 and a loss of 0.13 billion yuan in the same period last year. During the reporting period, the Company's overall sales revenue for conventional vaccines (excluding new crown vaccines) increased by no less than 16% year-on-year.

COSCO HAC: 2023 net profit pre-reduced by about 78.25% YoY

COSCO HAC (601919) disclosed its performance forecast on the evening of January 9. The company expects to realize earnings before interest and tax (EBIT) of about 36.643 billion yuan in 2023, a decrease of about 78.54 compared with the same period of last year; the net profit attributable to shareholders of listed companies in 2023 was about 23.859 billion yuan, a decrease of about 78.25 compared with the same period of last year. During the reporting period, the company's container shipping business revenue decreased year-on-year, resulting in a decrease in the current period's performance compared with the same period last year.

laurel power: 2023 net profit pre-reduced by about 61.55-64.66% year-on-year

Laurel Power (600236) disclosed its performance forecast on the evening of January 9. The company expects to achieve a net profit of about 1.134 billion -1.234 billion yuan in 2023, a year-on-year decrease of about 61.55-64.66; basic earnings per share are about 0.13 yuan/share -0.15 yuan/share. In 2023, the company's backbone power plant is located in the Red River basin, the water than the average of five to 60 percent dry, resulting in a reduction in power generation. The company's hydropower stations in Sichuan, Yunnan and Guizhou have also decreased their power generation to varying degrees compared with the same period last year due to the lack of water in the region.

China life: accumulated original insurance premium income in 2023 is about 641.5 billion yuan, up 4.3 year on year

China Life (601628) announced on the evening of January 9 that during the period from January 1, 2023 to December 31, 2023, the cumulative original insurance premium income was about 641.5 billion yuan, an increase of 4.3 percent over the same period last year.

Changan Automobile: Cumulative Car Sales 2.5531 million in 2023 Up 8.82 YoY

Chang 'an Automobile (000625) announced on the evening of January 9 that 215100 cars were sold in December 2023, down 15.91 per cent from a year earlier. Among them, the sales volume of self-owned brand new energy was 59366, up 31.27 year on year. Cumulative car sales in 2023 were 2.5531 million, up 8.82 percent year-on-year.

shennong group: pig sales revenue in December 2023 is 0.209 billion yuan

Shennong Group (605296) announced on the evening of January 9 that in December 2023, the company sold 129600 pigs (including 122400 commercial pigs) with a sales revenue of 0.209 billion yuan. In December 2023, the company's commodity pig prices showed a downward trend. The average selling price of commodity pigs was 13.53 yuan/kg, down 6.37 from November 2023. From January to December 2023, the company sold 1.5204 million pigs (including 1.4859 million commercial pigs) with a sales revenue of 2.693 billion yuan.

Minhe shares: sales revenue of commercial chicken seedlings increased 71.32 percent year on year in December 2023

Minhe shares (002234) announced on the evening of January 9 that 17.6506 million commercial chicken seedlings were sold in December 2023, up 77.56 percent year-on-year and down 19.10 percent month-on-month. Sales revenue was 21.335 million yuan, up 71.32 percent year-on-year and down 50.29 percent month-on-month. The main reason is that the incubation period of the previous year was concentrated in December 2022, and the incubation period of this year was across the month, resulting in a year-on-year increase in the incubation volume of this month and a decrease month-on-month.

tianbang food: sales revenue of commercial pigs in 2023 increased by 11.44 in 9.73 billion yuan year on year

tianbang food (002124) announced on the evening of January 9 that the company sold 844900 commercial pigs in December 2023, with a sales revenue of 0.926 billion yuan and an average sales price of 13.51 yuan/kg (the average price of commercial fat pigs is 13.43 yuan/kg), with month-on-month changes of -5.06%, 0.61% and -3.89% respectively. From January to December 2023, 7.1199 million commercial pigs were sold, with sales revenue of 9.73 billion yuan and average sales price of 14.97 yuan/kg (average price of commercial fat pigs was 14.75 yuan/kg), with year-on-year changes of 61.03, 11.44 and -18.39 respectively.

luo niushan: cumulative pig sales revenue in 2023 1.337 billion yuan decreased by 1.43 year on year

Luo Niushan (000735) announced on the evening of January 9 that the company sold 71800 pigs in December 2023, with sales revenue of 0.111 billion yuan, with a month-on-month change of -9.65% and -20.41%, respectively, and a year-on-year change of 33.31% and -16.12%, respectively. From January to December 2023, the company sold 779200 pigs, up 55.73 percent from the same period last year, and the cumulative sales revenue was 1.337 billion billion yuan, down 1.43 percent from the same period last year.

tiankang biology: pig sales revenue in December 2023 increased by 8.09 year on year

tiankang biology (002100) announced on the evening of January 9 that 279800 pigs were sold in December 2023, with sales up 13.60 percent month on month and 40.74 percent year on year. Sales revenue was 0.401 billion yuan, up 5.80 percent month on month and 8.09 percent year on year. In December 2023, the average sales price of commercial pigs (after deducting piglets and breeding pigs) was 13.19 yuan/kg, down 2.30 from the previous month. From January to December 2023, the company sold a total of 2.8158 million live pigs, an increase of 38.90 percent over the same period last year, and cumulative sales revenue of 4.481 billion billion yuan, an increase of 21.44 percent over the same period last year.

China merchants shekou: the contracted sales amount in 2023 increased by 0.35 in 293.635 billion yuan year on year

China Merchants Shekou (001979) announced on the evening of January 9 that in December 2023, the company realized a contracted sales area of 1.2908 million square meters and a contracted sales amount of 22.759 billion yuan. From January to December 2023, the company achieved a total contracted sales area of 12.2341 million square meters, an increase of 2.49 percent over the same period last year, and a total contracted sales amount of 293.635 billion billion yuan, an increase of 0.35 percent over the same period last year.

ST Shimao: the contracted amount of real estate sales in 2023 is about 7.06 billion yuan, down 23% year on year

ST Shimao (600823) announced on the evening of January 9 that the company had no new real estate reserve projects from January to December 2023. From January to December 2023, the company's new real estate construction area was about 55000 square meters, a year-on-year decrease of 91%; the completed area was about 1.083 million square meters, a year-on-year increase of 91%; the sales contract area was about 418000 square meters, a year-on-year decrease of 40%; the sales contract The amount was about 7.06 billion yuan, a year-on-year decrease of 23%. From January to December 2023, the construction area of the company's leased real estate was about 1.72 million square meters, and the rental income was about 1.21 billion yuan, and the comprehensive rental rate was about 86%.

Sichuan road and bridge: the total amount of cumulative winning projects in 2023 increased by 20.07 year on year

Sichuan road and bridge (600039) announced on the evening of January 9 that the company had won the bid in 2023 with a total amount of 168.516 billion yuan, up 20.07 year on year.

[increase and decrease holdings, repurchase]

jingwei hengrun: plans to buy back the company's shares from 0.1 billion yuan to 0.2 billion yuan

Jingwei Hengrun (688326) announced on the evening of January 9 that the company intends to repurchase shares at 0.1 billion yuan to 0.2 billion yuan, which will be used for employee stock ownership plans or equity incentives at an appropriate time in the future, and the price of the repurchased shares will not exceed 173 yuan per share (including capital).

Jiuhe software: shares to be repurchased by 50 million yuan -0.1 billion yuan

Jiuhe software (002279) announced on the evening of January 9 that the company plans to buy back shares at 50 million -0.1 billion yuan for subsequent employee stock ownership plans or equity incentive plans. The repurchase price does not exceed 8 yuan/share.

chengda pharmaceutical: plans to buy back shares from 30 million yuan to 60 million yuan

Chengda Pharmaceutical (301201) announced on the evening of January 9 that the company intends to repurchase shares at 30 million -60 million yuan for the implementation of employee stock ownership plans or equity incentives. The repurchase price does not exceed $38 per share.

Ming Xin xuteng: the actual controller and chairman proposed to buy back shares at 20 million yuan to 40 million yuan

Ming Xin xuteng (605068) announced on the evening of January 9 that Zhuang junxin, the company's actual controller and chairman, proposed that the company use its own funds to buy back some of the company's a shares by means of centralized bidding, and use the aforementioned repurchased shares for employee stock ownership plan or equity incentive at an appropriate time in the future. The total amount of funds for share repurchase shall not be less than 20 million yuan (inclusive) and not more than 40 million yuan (inclusive).

aike blue: proposed 15 million yuan -30 million yuan share buyback

Aikelan (300816) announced on the evening of January 9 that the company plans to buy back shares for 15 million -30 million yuan for equity incentive or employee stock ownership plan. The repurchase price shall not exceed 37.48 yuan/share.

Hongchuan Wisdom: The actual controller plans to increase the company's shares by no less than 5 million yuan

Hongchuan Wisdom (002930) announced on the evening of January 9 that Lin Haichuan, the actual controller, chairman and general manager of the company, plans to increase his holdings of the company's shares through centralized bidding transactions or bulk transactions within the next 6 months from the date of disclosure of this announcement; the amount of this increase is not less than 5 million yuan, and no price range is set.

Pathfinder: the controlling shareholder's concerted action person intends to reduce the company's shares by no more than 1.9999

pathfinder (300005) announced on the evening of January 9 that baiyi qianshun, the controlling shareholder who holds 2.0069 of the shares, plans to reduce the company's shares by no more than 17.539 million shares (accounting for no more than 1.9999 of the company's total share capital) through bulk trading or centralized bidding (including after-hours pricing) within 3 months after 15 trading days.

Jianyi Group: Shareholder Sun Yun Plans to Reduce 1.43 of Company Shares

Jianyi Group (002789) announced on the evening of January 9 that Sun Yun, a 1.43 shareholder, plans to reduce his holdings of 2.2899 million shares (accounting for 1.43 of the company's total share capital) by centralized bidding and block trading within 90 natural days after 3 trading days.

[Refinancing]

xujie xing: the proposed increase in capital will not exceed 0.34 billion yuan

xunjiexing (688655) announced on the evening of January 9 that the company plans to issue shares to specific targets to raise no more than 0.34 billion yuan, which will be used for Zhuhai xunjiexing intelligent model production base project (phase I) and supplementary working capital after deducting the issuance expenses. On the same day, the company announced that it intends to terminate the issuance of convertible corporate bonds to non-specific objects.

[Major investment]

Dashi Intelligence: Intends to set up a wholly-owned subsidiary in Malaysia

Dashi intelligence (002421) announced on the evening of January 9 that the board of directors of the company deliberated and passed the proposal on the establishment of a wholly-owned subsidiary in Malaysia, and planned to set up a wholly-owned subsidiary in Malaysia with its own capital of 30 million yuan. After the establishment of the subsidiary, the subsidiary will be engaged in smart space products, solutions and technical services.

gansu energy chemical: project to build two coal preparation plants

Gansu nenghua (000552) announced on the evening of January 9 that the company plans to implement the Weijiadii coal mine coal preparation plant project and the Dashuitou coal mine coal preparation plant project. the project will be established by Gansu jingmei energy co., ltd. (hereinafter referred to as "jingmei company"), a wholly-owned subsidiary, with a total capital of 0.704 billion yuan, through its own funds or loans from banks and other financial institutions. On the same day, it was announced that Jingmei Company intends to increase the capital of its wholly-owned subsidiary Baiyin Thermal Power by 0.9 billion yuan. The wholly-owned subsidiaries Coal No.1 Company and Huaneng Company will increase their capital by 50 million yuan respectively.

[the winning contract]

Shanghai construction engineering: subsidiary won the bid of 4.753 billion yuan project

Shanghai construction engineering (600170) announced on the evening of January 9 that recently, its subsidiary Shanghai construction engineering group co., ltd. won the bid for the office and commercial new project (except pile foundation project) on plot 19-01 in Shanghai jinding, with a bid price of 4.753 billion yuan.

beixin road and bridge: total bid 2.888 billion yuan expressway construction contract

Beixin Road and Bridge (002307) announced on the evening of January 9 that the company recently received the "Letter of Acceptance" from Xinjiang A'a Expressway Project Management Co., Ltd. The company has been identified as the winning bidder for the first and second contract sections of G3036 Aksu-Alar Expressway construction, with a total winning amount of 2.888 billion yuan.

Bailey Technology: Signed 0.838 billion Yuan Major Contract with Shanxi Tewashi

Bailey Technology (603959) announced on the evening of January 9 that the company and Shanxi Twash Energy Technology Co., Ltd. (hereinafter referred to as "Shanxi Twash") signed the EPC Contract for the Design, Procurement and Construction of 100000 Tons of Lithium Manganese Iron Phosphate Cathode Material Project of Shanxi Twash Energy Technology Co., Ltd. with a tentative total contract price of 0.838 billion yuan, it accounts for 26.04 of the company's audited operating income in the most recent year. If the contract is successfully performed on schedule, it is expected to have a positive impact on the company's current and future operating results.

Samsung Medical: Subsidiary won the bid of 0.836 billion yuan framework to purchase wind power photovoltaic pre-installed substation (Chinese, oil transformer) project

Samsung Medical (601567) announced on the evening of January 9 that the company recently received a notice from its wholly-owned subsidiary Oaks Intelligent Technology to win the bid in the 2024-2025 framework procurement of wind power photovoltaic pre-installed substation (Chinese, oil transformer) project of China Datang Group Co., Ltd. Oaks Intelligent Technology is the winning bidder for the above project, with a total bid amount of about 0.836 billion yuan. It accounts for 9.19 of the company's total audited operating income in 2022.

longjian shares: subsidiary won the bid for 0.778 billion yuan project

Longjian shares (600853) announced on the evening of January 9 that the company's subsidiary Heilongjiang Longjian Road and Bridge Second Engineering Co., Ltd. (referred to as "the second company") receivedNotice of Winning the Bid from Bayan County Transportation Bureau and Heilongjiang Rihui Engineering Project Management Co., Ltd., the tenderee: Company 2 was determined to be the successful bidder for the reconstruction and expansion project of Suihua-Shangzhi Highway from Suihua to Shangzhi. The bid price of the project is 0.778 billion yuan and the construction period is 730 days. The project represents approximately 4.59 percent of the Company's audited operating income in 2022.

tengda construction: winning the bid of 0.124 billion yuan project

Tengda Construction (600512) announced on the evening of January 9 that recently, the company received the "Letter of Acceptance" issued by Xianju County Transportation and Water Conservancy Development Group Co., Ltd., confirming that the company is the "Xianju County G351 National Highway Connection" in Taizhou City, Zhejiang Province The winning bidder of the construction project. The bid price of the project is 0.124 billion yuan and the construction period is 30 months.

ST Tianlong: Subsidiary Signed Major Contract for Daily Operation of 38.1809 million yuan

ST Tianlong (300029) announced on the evening of January 9 that Sichuan Zhongshu, a wholly-owned subsidiary of the company, recently signed the "Huaneng Shanxi Xiyang County Photovoltaic Power Generation Project Support Purchase Contract" with Shanghai Electric Power Construction Co., Ltd. (hereinafter referred to as "Shanghai Electric Power Construction"), with a total contract amount of 38.1809 million yuan (including tax). As of the announcement date, the company has signed contracts with Shanghai Power Construction and its subsidiaries for a total of 0.114 billion yuan (including tax) in 12 consecutive months, accounting for 47.50 of the company's total audited assets in 2022.

[Other]

northern rare earth: the trading price of rare earth concentrate in the first quarter of 2024 will be adjusted to 20737 yuan/ton excluding tax (dry volume, REO = 50%)

Northern Rare Earth (600111) announced on the evening of January 9 that the company and its related party Inner Mongolia Baotou Steel Co., Ltd. (referred to as "Baotou Steel Co., Ltd.") agreed that starting from April 1, 2023, under the condition that the pricing formula for rare earth concentrate remains unchanged, the company's managers will calculate and adjust the price of rare earth concentrate according to the pricing formula for rare earth concentrate, re-sign the rare earth concentrate supply contract or supplementary agreement and announce it. According to the pricing method of rare earth concentrate and the price of rare earth oxides in the fourth quarter of 2023, after calculation and approval by the company's first general manager's office meeting in 2024, the trading price of rare earth concentrate in the first quarter of 2024 is adjusted to 20737 yuan/ton excluding tax (dry volume, REO = 50%), and the price excluding tax is increased or decreased by 414.74 yuan/ton for every 1% increase or decrease of REO.

Yongtai Technology: Signed Supplementary Material Purchase Agreement with Ningde Times

Yongtai Technology (002326) announced on the evening of January 9 that the company signed a supplementary material purchase agreement with Ningde Times. Ningde Times intends to purchase not less than 100000 tons of various types of electrolyte from the company each year in 2024 and 2025 respectively. The signing and performance of this agreement will have a certain impact on the company's operating results in future years.

Xianhui Technology: Subsidiary signed a strategic cooperation agreement with Shanghai New Energy Vehicle Public Data Collection and Monitoring Research Center

Xianhui Technology (688155) announced on the evening of January 9 that the company's wholly-owned subsidiary Xianhui Big Data and Shanghai New Energy Vehicle Public Data Acquisition and Monitoring Research Center (referred to as the "Data Center") signed the "Strategic Cooperation Agreement", the two parties will cooperate around the market-oriented application of new energy vehicle big data, and jointly tap the commercial value of data through complementary resources and joint development. The content of the cooperation is to jointly develop projects and guarantee project funds for Xianhui Big Data. The data center provides data and technical support. The two sides jointly develop market-oriented application scenarios for new energy vehicle data, create data products, systems and technologies that serve different groups of people, and establish a benchmark service platform in the field of new energy vehicles.

Jinhui shares: 90.09 million yuan won the prospecting right for Dongpo lead-zinc mine in Hui county, Gansu province

jinhui shares (603132) announced on the evening of January 9 that the company participated in the bidding for the prospecting right of Dongpo lead-zinc mine in Hui county, Gansu province, and won the prospecting right for 90.09 million yuan. on January 9, 2024, the company signed the "confirmation letter for the transfer of prospecting right" with Gansu public resources trading center.

China Chemistry: Dai Hagen Resigns from Chairman and Other Positions

China Chemical (601117) announced on the evening of January 9 that due to work adjustments, Dai Hequen applied to resign from the company's chairman, director, chairman of the strategy committee of the board of directors, and member of the nomination committee of the board of directors. Upon resignation, Dai and Gen will no longer hold any position in the company.

Wanhua Chemical: Ningbo Industrial Park Phase I MDI Plant Resumed Production

Wanhua chemical (600309) announced on the evening of January 9 that the MDI phase I unit (400000 tons/year) of Wanhua chemical (Ningbo) co., ltd., a wholly-owned subsidiary of the company, began to stop production for maintenance on November 15, 2023. up to now, the shutdown for maintenance of the above MDI unit has been completed and normal production has resumed. The MDI Phase II unit (800000 tons/year) of Wanhua Chemical (Ningbo) Co., Ltd. is still under planned overhaul and will be announced separately after the overhaul.

Jin Dawei: wholly-owned subsidiary obtains food production license (Jin Qilin analyst) certificate

jindawei (002626) announced on the evening of January 9 that Inner Mongolia jindawei Pharmaceutical Co., Ltd., a wholly-owned subsidiary of the company, recently received the "food production license" issued by Hohhot administrative examination and approval and government service bureau, which has the production license of "fermented soybean products: other (natto powder)" (the main component is nattokinase).

Lizhu Group: provision for impairment of assets

Lizhu Group (000513) announced on the evening of January 9 that, based on the principle of prudence, the Company and its subsidiaries conducted impairment tests on the assets with signs of impairment within the scope of the Company's consolidated statements as of December 31, 2023, and made provision for impairment of the assets with signs of impairment. The total amount of credit impairment loss to be provided for this time is 15.7533 million yuan, and the total amount of asset impairment loss to be provided for is 0.309 billion yuan, which is mainly the inventory impairment loss of the holding subsidiary Zhuhai lizhu monoclonal antibody biotechnology co., ltd. The provision for asset impairment will reduce the Company's net profit attributable to shareholders of the parent company by $0.178 billion in 2023.

Wuzhou Spring Festival: to form a consortium to participate in the public delisting and transfer of shares of Luozhou Company

Wuzhou Spring Festival (603667) announced on the evening of January 9 that Luoyang Guohong Investment Holding Group Co., Ltd. (hereinafter referred to as "Guohong Group") publicly listed and transferred 13% equity of Luoyang LYC Bearing Co., Ltd. (hereinafter referred to as "Luozhou Company"). The company and Henan Aoluofu Yu Precision Manufacturing Private Equity Investment Fund Partnership (Limited Partnership) formed a consortium to participate in the public delisting and transfer of 13% equity of Luozhou company, among them, the company intends to directly transfer the proportion of 8.4972, corresponding to the public listing transfer reserve price investment of 0.231 billion yuan. Luo Axis Company is a domestic leader in the field of wind power bearings and shield machine bearings, and has a large market demand for high-precision wind power rollers. The proposed strategic investment in Luo Axis Company is conducive to the development of the company's wind power roller product market and the technical complementarity of both parties.

Rip Bio: Signed a cooperative development agreement for cat HCPC quadruple mRNA vaccine

Rip Biology (300119) announced on the evening of January 9 that the company recently signed a "cooperative development agreement for cat HCPC quadruple mRNA vaccine" with Jiangsu Shenji Biotechnology Co., Ltd. to jointly research and develop quadruple mRNA vaccines for cat rhinotracheitis, calicivirus disease, panleukopenia and feline chlamydia. This product belongs to the research and development of new technology, and there are certain uncertainties about whether it can be successfully developed, the time to market and the market promotion after the product is listed.

Jiangsu Wuzhong: cilostazol tablets passed generic drug consistency evaluation

Jiangsu Wuzhong (600200) announced on the evening of January 9 that recently, Suzhou Pharmaceutical Factory, a branch of Jiangsu Wuzhong Pharmaceutical Group Co., Ltd., a wholly-owned subsidiary of the company, received the approval of the State Food and Drug Administration on "Cilostazol Tablets" "Drug Supplementary Application Approval Notice", the drug passed the quality and efficacy consistency evaluation of generic drugs.

huahai pharmaceutical: paroxetine sustained-release tablets received FDA approval number

huahai pharmaceutical (600521) announced on the evening of January 9 that the company received a notice from the us food and drug administration (FDA) that the new drug brief application for paroxetine sustained-release tablets (ANDA, I .e. generic drug application in the United States) declared by the company to FDA has been approved.

Puli Pharmaceuticals: Acyclovir Sodium Injection Obtain US FDA Marketing Approval

Puli Pharmaceuticals (300630) announced on the evening of January 9 that the company recently received a marketing license for acyclovir sodium injection issued by the US Food and Drug Administration (FDA).

Baiyunshan: Gliclazide Tablets Pass Generic Drug Consistency Evaluation

Baiyunshan (600332) announced on the evening of January 9 that Guanghua Pharmaceutical, the company's holding subsidiary, recently received the ''Drug Supplement Application Approval Notice'' approved and issued by the State Drug Administration, and the drug gliclazide tablets have passed the generic Drug quality and efficacy consistency evaluation. Gliclazide tablets are used in adults with type 2 diabetes whose diet alone, physical exercise, and weight loss are insufficient to control blood glucose levels.